Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marzia Defina

Showing results (21-30 of 68) with videos related to

Pageof 7
Sort By:
Acta Haematologica|March 29, 2007
Pilot study of gemtuzumab ozogamicin (GO), fludarabine, cytarabine and idarubicin combined regimen (GO-FLAI) as first-line induction therapy plus GO alone as consolidation therapy for elderly acute myeloid leukemia patientsMaria Teresa Pirrotta, Monica Bocchia, Alessandro Bucalossi, et al.
Leukemia Research|March 15, 2011
Unusual localizations of plasmacytomaAlessandro Gozzetti, Giuseppe Coviello, Alberto Fabbri, et al.
Acta Haematologica|July 8, 2010
A der(1)t(1;21)(p36.3;q22) in a patient with acute myelogenous leukemia M2Alessandro Gozzetti, Rosaria Crupi, Michela Rondoni, et al.
Nature Reviews. Clinical Oncology|September 3, 2010
Complete molecular response in CML after p210 BCR-ABL1-derived peptide vaccinationMonica Bocchia, Marzia Defina, Lara Aprile, et al.
British Journal of Haematology|October 31, 2009
Lenalidomide on alternative days is effective in myelodysplastic syndrome with 5q- deletionMarzia Defina, Michela Rondoni, Alessandro Gozzetti, et al.
British Journal of Haematology|March 30, 2010
Reduction of imatinib dose and persistence of complete molecular response after p210 multipeptide vaccine in chronic myeloid leukaemia treated with dose escalation for acquired resistanceMassimo Breccia, Monica Bocchia, Laura Cannella, et al.
Clinical Case Reports|October 22, 2020
Venetoclax in association with decitabine as effective bridge to transplant in a case of relapsed early T-cell lymphoblastic leukemiaElisabetta Zappone, Emanuele Cencini, Marzia Defina, et al.
Cancer Genetics and Cytogenetics|February 2, 2010
Translocation(X;2)(q26;q11.2) in a patient with acute myeloid leukemia M2 evolved from essential thrombocytemiaAlessandro Gozzetti, Rosaria Crupi, Michela Rondoni, et al.
British Journal of Haematology|February 3, 2012
Efficacy of bortezomib, lenalidomide and dexamethasone (VRD) in secondary plasma cell leukaemiaAlessandro Gozzetti, Pellegrino Musto, Marzia Defina, et al.
Cancer Genetics and Cytogenetics|June 9, 2007
Deletion 9q in a patient with concomitant myelodysplasia and non-Hodgkin lymphomaAlessandro Gozzetti, Simona Calabrese, Rosaria Crupi, et al.
Pageof 7

Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
Acta Haematologica|March 29, 2007
Pilot study of gemtuzumab ozogamicin (GO), fludarabine, cytarabine and idarubicin combined regimen (GO-FLAI) as first-line induction therapy plus GO alone as consolidation therapy for elderly acute myeloid leukemia patientsMaria Teresa Pirrotta, Monica Bocchia, Alessandro Bucalossi, et al.
Leukemia Research|March 15, 2011
Unusual localizations of plasmacytomaAlessandro Gozzetti, Giuseppe Coviello, Alberto Fabbri, et al.
Acta Haematologica|July 8, 2010
A der(1)t(1;21)(p36.3;q22) in a patient with acute myelogenous leukemia M2Alessandro Gozzetti, Rosaria Crupi, Michela Rondoni, et al.
Nature Reviews. Clinical Oncology|September 3, 2010
Complete molecular response in CML after p210 BCR-ABL1-derived peptide vaccinationMonica Bocchia, Marzia Defina, Lara Aprile, et al.
British Journal of Haematology|October 31, 2009
Lenalidomide on alternative days is effective in myelodysplastic syndrome with 5q- deletionMarzia Defina, Michela Rondoni, Alessandro Gozzetti, et al.
British Journal of Haematology|March 30, 2010
Reduction of imatinib dose and persistence of complete molecular response after p210 multipeptide vaccine in chronic myeloid leukaemia treated with dose escalation for acquired resistanceMassimo Breccia, Monica Bocchia, Laura Cannella, et al.
Clinical Case Reports|October 22, 2020
Venetoclax in association with decitabine as effective bridge to transplant in a case of relapsed early T-cell lymphoblastic leukemiaElisabetta Zappone, Emanuele Cencini, Marzia Defina, et al.
Cancer Genetics and Cytogenetics|February 2, 2010
Translocation(X;2)(q26;q11.2) in a patient with acute myeloid leukemia M2 evolved from essential thrombocytemiaAlessandro Gozzetti, Rosaria Crupi, Michela Rondoni, et al.
British Journal of Haematology|February 3, 2012
Efficacy of bortezomib, lenalidomide and dexamethasone (VRD) in secondary plasma cell leukaemiaAlessandro Gozzetti, Pellegrino Musto, Marzia Defina, et al.
Cancer Genetics and Cytogenetics|June 9, 2007
Deletion 9q in a patient with concomitant myelodysplasia and non-Hodgkin lymphomaAlessandro Gozzetti, Simona Calabrese, Rosaria Crupi, et al.
Pageof 7